Data from half-a-million people was assessed by the University of Aberdeen research team.

Source

Lenacapavir, which stops HIV from replicating inside cells, has passed early safety tests.

Source

Frequent donors were more likely to have different genetic changes in their blood stem cells, scientists found.

Source